IL-13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat!
- PMID: 33583056
- DOI: 10.1111/all.14772
IL-13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat!
Keywords: IL-13; T2 inflammation; airway microbiome; neutrophils; severe asthma.
Comment on
-
Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma.Allergy. 2021 Jul;76(7):2070-2078. doi: 10.1111/all.14732. Epub 2021 Jan 26. Allergy. 2021. PMID: 33411348 Free PMC article.
References
REFERENCES
-
- Azim A, Green B, Lau L, et al. Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma. Allergy. 2021;76(7):2070-2078.
-
- Ward C, Gardiner PV, Booth H, Walters EH. Intrasubject variability in airway inflammation sampled by bronchoalveolar lavage in stable asthmatics. Eur Respir J. 1995;8(11):1866-1871.
-
- Aleman F, Lim HF, Nair P. Eosinophilic endotype of asthma. Immunol Allergy Clin North Am. 2016;36(3):559-568.
-
- Chu DK, Al-Garawi A, Llop-Guevara A, et al. Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma. Allergy Asthma Clin Immunol. 2015;11(1):1-6.
-
- Cox C, Kjarsgaard M, Surette M, Cox P, Nair P. A multidimensional approach to the management of severe asthma: inflammometry, molecular microbiology and bronchial thermoplasty. Can Respir J. 2015;22(4):221-224.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
